ArticleBreast cancer (Tokyo, Japan)2023

Is there any association between acute kidney injury and olaparib use in patients with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial.

No numbers read from the abstract.

Not cited yet